166108-71-0 Fmoc-AEEA-OH bụ njikọ ADC nwere ike ihichapụ nke ejiri na njikọ nke conjugates antibody-ọgwụ (ADCs).Fmoc-8-amino-3,6-dioxaoctanoic acid bụkwa ihe njikọ PROTAC dabeere na PEG nke enwere ike iji na njikọ nke PROTAC.
166108-71-0 Fmoc-AEEA-OH nwekwara ike ịbụ otu n'ime semaglutide Intermediates.
Isi mmetụta nke semaglutide bụ ịgwọ ụdị ọrịa shuga 2 site na ibelata ọkwa glucose ọbara.Ọ na-eṅomi insulin-dị ka peptide-1 hormone, nke na-akpali mmepụta insulin na-egbochi mwepụta nke glucagon, si otú ahụ na-ebelata ọkwa glucose ọbara.Semaglutide anaghị etinye aka na ihe ize ndụ nke hypoglycemia na-eme ma e jiri ya tụnyere ọgwụgwọ insulin nke mbụ n'ihi na usoro ya dị mgbagwoju anya na nke ziri ezi.Site n'ịgbanwe nguzozi nke insulin na glucagon, somalutide nwere ike inyere ndị nwere ụdị ọrịa shuga 2 aka ịchịkwa ọkwa shuga ha nke ọma.
Na mgbakwunye na ibelata ọkwa shuga dị n'ọbara, semaglutide nwekwara ike ibelata ibu ahụ.Nke a bụ n'ihi mmetụta na-egbochi agụụ ya.semaglutide na-akpali ọrụ nke satiety center na hypothalamus, nke na-ebelata agụụ.Isi uru nke semaglutide na ọgwụ ndị ọzọ na-ebelata ibu bụ na ọ na-atụfu ibu ma na-eme ka nguzogide insulin na njikwa shuga ọbara dịkwuo elu.Nke a na-eme ka ọ bụrụ nhọrọ ọgwụgwọ a na-achọsi ike maka ndị ọrịa nwere ọrịa shuga nwere oke ibu.
Na mgbakwunye, semaglutide na-eme ka ọrụ pancreatic dịkwuo mma ma na-ebelata nzaghachi mkpali na mkpụrụ ndụ islet pancreatic.Ọ na-echebe mkpụrụ ndụ agwaetiti pụọ na mmebi ọzọ nke ọrịa shuga na-akpata ma na-akwalite mmụgharị mkpụrụ ndụ agwaetiti.Nke a dị mkpa karịsịa maka ndị nwere ọrịa shuga 2dị nke abụọ, n'ihi na oke mmebi nke cell cell nwere ike iduga ọdịda nke agwaetiti.
N'ozuzu, semaglutide bụ ọgwụ dị oke mma yana nchekwa maka ọgwụgwọ ụdị ọrịa shuga 2.Ọ na-enyere ndị ọrịa aka ịchịkwa ọrịa shuga ha nke ọma ma belata nsogbu site n'iweda ọkwa glucose ọbara, ibelata ibu ahụ, meziwanye ọrụ agwaetiti, na ichekwa mkpụrụ ndụ agwaetiti.Ọmụmụ ihe n'ọdịnihu ga-enyochakwu ikike nke somatostatin na ọgwụgwọ ọrịa ndị ọzọ, dị ka NAFLD na oke ibu.